Quarterly Results, Broker Conferences, Special IR Events FY2018 (April 2018-March 2019）

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download

Press Release

Pipeline Supplemental
Click to download

Earnings Release Presentation

For Media
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download

For Investors and Analysts
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download

Audio Conference Call Part 1

Audio Conference Call Part 2

Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation
Click to download

Quarterly Securities Report (FY2018 Q3)
Click to download 

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download

Data Book
Click to download

Earnings Release Presentation

1．Strategic Focus & Superior Execution FY2018 Q3 Results
Costa Saroukos, Chief Financial Officer
Click to download

2．Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation

Click to download

Audio Conference Call Part 1

Audio Conference Call Part 2

Presentation
J.P. Morgan Healthcare Conference Presentation
Click to download

Audio
・Conference call
・Q&A

*Link to J.P.Morgan website

Presentation
A Global, Values-based, R&D-driven Biopharmaceutical Leader
Click to download

Click here to see the video (for IR)

Consolidated Statement of Cash Flows
Click to download 

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download

News Release

Data Book
Click to download

Earnings Release Presentation
For Media:
Strategic Focus & Superior Execution FY2018 Q2 Results
Christophe Weber, President & Chief Executive Officer
Click to download

For Investors & Analysts:
Strategic Focus & Superior Execution FY2018 Q2 Results
Christophe Weber, President & Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Costa Saroukos, Chief Financial Officer
Click to download

Creating a Values based, R&D driven Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Click to download

Supplementary materials for the financial statements: Underlying Core Reconciliation
Click to download

Click here to listen to the Audio

Presentation
DELIVERING ON OUR R&D VISION

Andy Plump, Chief Medical and Scientific Officer

Click to download

• Oncology
• Gastroenterology
• Neuroscience
• Vaccines

Video
*Link to Digital Media Solutions’ website

Presentation
DELIVERING ON OUR R&D VISION

Andy Plump, Chief Medical and Scientific Officer

Click to download

• Oncology
• Gastroenterology
• Neuroscience
• Vaccines
• Shonan iPark

Video
*Link to Nomura IR's website

Consolidated Statement of Cash Flows
Click to download 

Consolidated Financial Statements submitted to TSE(Tokyo Stock Exchange)
(Without Independent Auditor's report)
Click to download

Data Book
Partial correction of Data Book(September 11th,2018)
Click to download(After correction)

Earnings Release Conference Call
1. Consolidated Financial Results for FY2018 Q1
Costa Saroukos, Chief Financial Officer
Click to download

2. Supplemantary materials for the financial statements: Underlying Core Reconciliation
Click to download

Click here to listen to the Audio

Presentation
Takeda to Acquire Shire-Accelerating Takeda’s Transformation to Deliver More for Patients

Click here to download

Presentation website for Investors (from 4:15pm)

Click here to listen to the audio for May 8th (for Media & IR)

Click here to listen to the audio for May 9th (for Media & IR)

FY2017 (April 2017-March 2018)
FY2016 (April 2016-March 2017)
FY2015 (April 2015-March 2016)
FY2014 (April 2014-March 2015)
FY2013 (April 2013-March 2014)
FY2012 (April 2012-March 2013)